Lebwohl, Mark G, Jeffrey L Sugarman, Linda Stein Gold, Tina Lin, and Gina Martin. 2019. “Efficacy, Safety, and Tolerability of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination in the Treatment of Severe Plaque Psoriasis: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials”. SKIN The Journal of Cutaneous Medicine 3 (November):S29. https://doi.org/10.25251/skin.3.supp.29.